SEC 13F Intelligence

Sjs Investment Consulting Inc. / LLY

Sjs Investment Consulting Inc.’s Eli Lilly & Co Position

Does Sjs Investment Consulting Inc. own Eli Lilly & Co (LLY)? Yes19.1K shares worth $18M (+2.15% of its 13F portfolio) as of Q1 2026, up from 19.1K shares the prior filed quarter.

Position Value
$18M
Q1 2026
Shares
19.1K
% of Portfolio
+2.15%
Quarters Held
17
currently held

Position History LLY

Reported value by quarter
Q4 ’21: $5MQ4 ’21Q1 ’22: $5MQ3 ’22: $6MQ4 ’22: $7MQ4 ’22Q1 ’23: $6MQ2 ’23: $9MQ3 ’23: $10MQ3 ’23Q4 ’23: $11MQ1 ’24: $15MQ2 ’24: $17MQ2 ’24Q3 ’24: $17MQ4 ’24: $14MQ1 ’25: $15MQ1 ’25Q2 ’25: $15MQ3 ’25: $15MQ4 ’25: $20MQ4 ’25Q1 ’26: $18Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202619.1K$18M+2.15%
Q4 202519.1K$20M+2.59%
Q3 202519.0K$15M+1.99%
Q2 202518.7K$15M+2.32%
Q1 202518.8K$15M+2.64%
Q4 202418.7K$14M+2.50%
Q3 202419.2K$17M+2.99%
Q2 202419.1K$17M+3.35%
Q1 202419.1K$15M+2.96%
Q4 202318.8K$11M+2.48%
Q3 202318.8K$10M+2.54%
Q2 202318.9K$9M+2.22%
Q1 202318.8K$6M+1.76%
Q4 202219.0K$7M+2.07%
Q3 202219.1K$6M+2.09%
Q1 202218.9K$5M+1.66%
Q4 202118.8K$5M+1.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sjs Investment Consulting Inc.’s full portfolio or all institutional holders of LLY.